2006
DOI: 10.1128/jvi.00510-06
|View full text |Cite|
|
Sign up to set email alerts
|

Phylogenetic Analysis of Polyomavirus BK Sequences

Abstract: Polyomavirus BK (BKV) has emerged as an important pathogen in kidney transplant patients. Existing taxonomic classifications of BKV come from conventional DNA sequence alignments based on limited data derived from the VP1 gene. We have used a phylogenetic whole-genome approach to examine the pattern of diversity and evolutionary relationships between 45 BKV strains isolated from multiple clinical settings. This analysis supports the classification of BKV into six genotypes, of which types V and VI have not bee… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

3
47
0

Year Published

2007
2007
2022
2022

Publication Types

Select...
8

Relationship

3
5

Authors

Journals

citations
Cited by 56 publications
(50 citation statements)
references
References 44 publications
3
47
0
Order By: Relevance
“…Our findings raise the interesting question of whether different BKV genotypes or subgenotypes exhibit altered tissue tropism or different levels of virulence in vivo. Although previous studies have surveyed BKV genotypes found in nephropathic lesions (15,16,(37)(38)(39), these studies have relied on BKV-I-biased PCR primers that underestimate the abundance of BKV genotypes II, III, and IV (40). The possibility that commonly used PCR primers do not robustly detect non-genotype I BKVs (particularly in the case of individuals coinfected with multiple BKV genotypes) is consistent with our observation that BKV-II seroprevalence (Fig.…”
Section: Discussionsupporting
confidence: 79%
“…Our findings raise the interesting question of whether different BKV genotypes or subgenotypes exhibit altered tissue tropism or different levels of virulence in vivo. Although previous studies have surveyed BKV genotypes found in nephropathic lesions (15,16,(37)(38)(39), these studies have relied on BKV-I-biased PCR primers that underestimate the abundance of BKV genotypes II, III, and IV (40). The possibility that commonly used PCR primers do not robustly detect non-genotype I BKVs (particularly in the case of individuals coinfected with multiple BKV genotypes) is consistent with our observation that BKV-II seroprevalence (Fig.…”
Section: Discussionsupporting
confidence: 79%
“…Subtypes V and VI, previously defined by us on the basis of more limited sequence data, are best considered to be subgroups of subtype I and clustered with Ib2 and Ib1, respectively. Subgroups of subtype I are shown to be definite phylogenetic entities separated by bootstrap values of 100%, which are much better than those previously obtained using more limited sequence information based on the VP1 gene (33). Bootstrap values for subgroups of subtype IV ranged from 68 to 87%.…”
Section: Resultsmentioning
confidence: 81%
“…A fragment within the T-Ag gene, from nucleotides 2993 to 3738, was amplified and sequenced only for subtyping of genotype IV samples. DNA was amplified with Hot Start PCR master mix (Biotech Rabbit), using the published primer pairs VP1-3 plus SeqB-11 and SeqB-16 plus SeqB-19 (3,14). Cycle sequencing of the purified amplicons was performed using an Applied Biosystems BigDye Terminator v1.1 kit according to the manufacturer's instructions.…”
Section: Methodsmentioning
confidence: 99%
“…With the growing importance of BKV in the management of immunocompromised patients over recent years, several manufacturers have developed commercial blood and urine BKV DNA quantification assays based on real-time PCR technology. Our knowledge of BKV genomic diversity has also improved considerably (4,10), as a large number of studies of full-genome BKV DNA have been published over the last decade (3,11). However, it is very difficult to provide clinicians with accurate data, because most methods are in-house methods and no international standards have yet been established to allow comparisons between different tests.…”
mentioning
confidence: 99%
See 1 more Smart Citation